Identification of a new gene product of PKIβ by HPLC–ESIMS

H. Song,G. Yue,Z. Zhou,Y. Xie,P. Yang,Y. Mao,Y. Xu,H. Wang
DOI: https://doi.org/10.1007/s002160100840
2001-01-01
Abstract:An identification method using high-performance liquid chromatography combined with electrospray mass spectrometry (HPLC–ESIMS) has been developed to verify an expressed gene product of kinase inhibitor (PKI β ). This protein was expressed in this university for the first time from a newly cloned gene in the cDNA library of human fetal brain. The measured MW (8468.9 Da) of PKI β -78 was consistent with expectations. The gene product of PKI β -78 was monitored by ESIMS to ensure there was no mis-expressed PKI β -70 in the process of gene engineering. The peptide mapping of PKI β -78 and its partial sequence were, furthermore, determined. By database searching based on the experimental MWs and partial sequences provided, it was verified that this gene product is a new protein. The pseudosubstrate site and leucine-rich site for the function region of PKI β -78 are also confirmed.
What problem does this paper attempt to address?